A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy

Clin Chim Acta. 2019 Aug:495:355-357. doi: 10.1016/j.cca.2019.04.083. Epub 2019 May 2.

Authors

Katharine Mackett¹, Sukhbinder Dhesy-Thind², Elysia K Donovan², Som Mukherjee², Anand Swaminath², Darryl P Leong³, Sachi Voruganti², Jonathan Sussman², James Wright², Gordon Okawara², Graham Fraser², Stephen Sagar², Louise Bordeleau², Peter M Ellis², Hal Hirte², Peter A Kavsak⁴

Affiliations

¹ Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
² Department of Oncology, McMaster University, Hamilton, ON, Canada.
³ Division of Cardiology and the Population Health Research Institute, McMaster University, Hamilton, ON, Canada.
⁴ Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: kavsakp@mcmaster.ca.

PMID: 31054914
DOI: 10.1016/j.cca.2019.04.083

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Biomarkers / metabolism
Chemoradiotherapy, Adjuvant / adverse effects*
Female
Heart / drug effects
Heart / radiation effects
Humans
Male
Middle Aged
Myocardium / metabolism*
Neoplasms / drug therapy
Neoplasms / metabolism*
Neoplasms / radiotherapy
Neoplasms / therapy*
Young Adult

Substances

Biomarkers